Four dicoumarols (DC, 2-PyDC, 3-PyDC and 4-PyDC) were synthesized and characterized via IR 
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Introduction
Staphylococcus aureus (S. aureus) is a main pathogen responsible for a number of diseases ranging from skin and soft tissue infections to life-threatening endocarditis in hospitals and community settings. S. aureus infections are a leading cause of healthcare-associated infections and associated with in-hospital mortality as high as 15% to 60%, especially in critically ill patients [1] [2] [3] . Methicillin-resistant S. aureus (MRSA) is the cause of major outbreaks and epidemics in hospitalized patients because of the emergence, spread, and rapid evolution of resistance genes developing among pathogens. As such, the mortality and morbidity rates of patients affected by MRSA are high [4, 5] . A number of schemes recently resulted in a dramatic increase in the total number of S. aureus bacteremia cases reported annually, and the proportion of such cases involving MRSA increased from 2% in 1990 to > 40% in the early 2000s [6, 7] . Vancomycin is currently the most effective antibiotic treatment for MRSA. However, the emergence of vancomycin-resistant MRSA and the treatment failure of MRSA infections suggest the urgent necessity of developing new antimicrobials.
Coumarin (2H-chromen-2-one) and its derivatives are widely distributed in nature and exhibit a broad pharmacological profile. Dicoumarols are often discussed because of their special molecular structures [two intramolecular O-H···O hydrogen bonds (HBs)] and diverse biological properties through chemical modifications (different substituents on the central linker methylene). Many studies have recently associated the function of dicoumarols with several bioactivities, including anticoagulant, insecticidal, antihelminthic, hypnotic, and antifungal activities, phytoalexin production, and HIV protease inhibition [8] [9] [10] [11] . Given the considerable importance of the compounds, researchers focused on the synthesis of dicoumarol derivatives.
To identify more active compounds, we prepared a series of dicoumarols, namely, 3,3′-methylenedi(4-hydroxycoumarin) (DC), 3,3′-(2-pyridinomethylene)di(4-hydroxycoumarin) (2-PyDC), 3,3′-(3-pyridinomethylene)di(4-hydroxycoumarin) (3-PyDC), and 3,3′-(4-pyridinomethylene)di(4-hydroxycoumarin) (4-PyDC) (Fig. 1) , and then evaluated their antibacterial activities. A possible relationship between such hydrogen-bonded structures and their antibacterial activities was further investigated by theoretical calculations. 
Results

Molecular structure
The crystal structure of DC is presented in Fig. 2 . In the crystal structure of DC, two 
Quantum chemical calculations
Geometric parameters of DC, 2-PyDC, 3-PyDC and 4-PyDC
The fully optimized molecular structures of DC, 2-PyDC, 3-PyDC and 4-PyDC with atomic numbering calculated at B3LYP level of theory [12] are shown in Fig. 3 . For compound DC, selected calculated geometric parameters under three different basis sets (6-31G*, 6-31+G**, and 6-311G*) and experimental geometric parameters are presented in Table 1 . As shown in Table 1 , the maximum deviations of the selected bond lengths between theoretical and experimental data were 0.02, 0.018, and 0.019 Å under three different basis sets. The maximum deviations of the selected bond angles between theoretical and experimental data were 0.91°, 1.2°, and 0.95°. The values of the three different basis sets were very close, and the calculated results agreed with the experimental findings. B3LYP/6-31G* exhibited sufficient agreement with experimental data and lower computational cost, so further theoretical study was performed at this level. Table 1 Experimental and calculated parameters of the selected bond lengths and bond angles of DC Name definition DC X-ray 6-31G* 6-31+G** 6-311G* 4 and O 1 ···O 6 in 2-PyDC, 3-PyDC, and 4-PyDC was greater than that in compound DC. This result is attributed to the structure of compound DC in which two 4-hydroxycoumarin moieties were linked through a methylene bridge, on which one hydrogen atom was replaced with a pyridine ring forming new structures of 2-PyDC, 3-PyDC, and 4-PyDC. For example, we take compound DC to estimate single and total HB energies. The global minimum structure was stabilized by two hydroxyl bonds (HBs); two higher energy structures were stabilized by one HB (DC1 and DC2). (Table 3) . DC2 was obtained from the global minimum structure of DC, but H 3 was rotated around the C 3 -O 3 bond until O 3 -H 3 ···O 4 HB rupture occurred [13, 14] . The total HB energy in DC, calculated by the
, was estimated to be -119.16 kJ/mol (Table 3) .
Compared with compound DC, the O 3 -H 3 ···O 4 HB energy for 2-PyDC, 3-PyDC, and 4-PyDC was stronger than O 6 -H 6 ···O 1 HB energy (Table 3) (Table 3) . Table 4 . Table 4 shows that the compounds DC, 2-PyDC, 3-PyDC, and 4-PyDC with both HBs exhibited low ρ b and positive ▽ 2 ρ b values, which further indicated the electrostatic character of the HBs [15] . The HBs in DC were symmetrical, and the calculated ρ b and ▽ 2 ρ b for the O···H bonding in the upper and lower exocyclic ring was consistent with each other. However, the HBs in 2-PyDC, 3-PyDC, and 4-PyDC were unsymmetrical, and the calculated ρ b and ▽ 2 ρ b for the O···H bonding in the upper exocyclic ring were higher than those in the lower exocyclic ring. The results were consistent with the stronger HB strength in the upper exocyclic ring for 2-PyDC, 3-PyDC, and 4-PyDC after introducing three different pyridine rings on the methylene group of compound DC (as was found from the calculated HB energies). Table 4 Properties of the electron density at bond critical points, ρ b and its Laplacian,▽ 
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Minimal inhibitory concentration (MIC) assay
Four S. aureus bacterial strains, including one drug-sensitive S. aureus (S. aureus ATCC 29213) strain and three MRSA strains (MRSA XJ 75302, Mu50, USA 300 LAC), were used in the systematic analysis of the antibacterial activities of DC, 2-PyDC, 3-PyDC and 4-PyDC in vitro. Because of the liposolubility of the four compounds, they were dissolved into the solution with 1% Dimethyl sulfoxide (DMSO) at final concentration. As shown in Table 5 , among the compounds, 2-PyDC exerted the most potent bactericidal effects against nearly all types of S. aureus tested, including USA 300 LAC, which is a highly virulent and widespread clinical isolate that causes the recent epidemic of MRSA infections. The MIC values of 2-PyDC ranged from 16 to 64 µg/mL. By contrast, other compounds exerted weaker bactericidal effects against S. aureus, and their MIC values exceed 256 µg/mL for S. aureus (ATCC 29213) and the three MRSA strains. Compared with the MIC values of the above compounds, the MIC values of levofloxacin, ceftazidime, ceftriaxone, gentamicin and piperacillin against S. aureus (ATCC 29213) strains were lower (less than 8 µg/mL) but were higher against resistant strains at varying degrees. The results showed that 2-PyDC has the most potent broad-spectrum antibacterial activity on the drug-sensitive and drug-resistant S. aureus in vitro. 
Bacterial growth inhibition
We further investigated the growth inhibitory and bactericidal effects to gain insight into the mode of action of compound 2-PyDC. Additional experiments were performed to determine the growth rate of S. aureus in liquid medium containing the different concentrations of the compound. The compound 2-PyDC was added to cultures at concentrations of 4, 8, 16, 32 or 64 µg/mL to evaluate the growth inhibitory effects on S. aureus ATCC 29213, MRSA XJ 75302, Mu50, and MRSA USA 300 LAC. As shown in Fig. 4A , 2-PyDC significantly inhibited the growth of the drug-sensitive S. aureus ATCC 29213 at 16 µg/mL and exhibited almost complete growth inhibition on this pathogen at 32 or 64 µg/mL. Although 2-PyDC was not able to effectively inhibited the growth of the drug-resistant strains MRSA XJ 75302 (Fig. 4B) , exhibited almost complete growth inhibition on Mu50 (Fig. 4C) , and MRSA USA 300 LAC (Fig. 4D) at 16 , 32 or 64 µg/mL. Similar to the results of the MIC values, the other compounds hardly showed any inhibitory effects on these pathogens at these concentrations (data was not shown). S. aureus growth in MH broth without any compounds, which was used as the control sample, did not exhibit any significant growth inhibitory effect. The analysis of bacterial growth inhibition showed that aside from exerting antibacterial activities on S. aureus, 2-PyDC also inhibited the growth of the drug-sensitive and drug-resistant S. aureus strains. 
In Vitro Toxicity measurement
To further explore the safety for the possible development, we investigated compound 2-PyDC cytotoxicity to human umbilical vein endothelial cells (HUVECs) and human embryonic cardiomyocytes cell line CCC-HHM-2 (HHHM-2) in vitro. As shown in Fig. 5 , there was no significant difference on cell viability between the control group and compound 2-PyDC treated group under concentration of 200 µg/mL (P> 0.05), and the IC50 to the HUVECs and HHHM-2 was 765.34 µg/mL and 786.96 µg/mL, respectively. These results implied that compound 2-PyDC had much less toxicity to mammalian cells, and had a relatively wide safety range for potential antimicrobial applications. 
Discussion
To get ahead of the problem on resistance, we must look for first-in-class antibacterials and new targets. Anti-bacterial activity and drug resistance of bacteria have a close relationship with the structure of antibiotics, hence the discovery of antibiotics with novel structures and the development of drugs against MRSA are highly active fields [16, 17] . Dicoumarols is a plant-derived natural product known for its wide pharmacological properties, such as anti-inflammatory and anticoagulant attributes [18] . No antibiotic that has a similar structure as dicoumarol derivatives is clinically being used for infection treatment. In this work, novel dicoumarol derivative 2-PyDC was demonstrated to be capable of significantly inhibiting the growth of multi-drug-resistant S. aureus. The MIC values showed the efficacy of 2-PyDC at a range of 16 to 64 µg/mL against S. aureus (ATCC 29213), MRSA (XJ 75302), Mu50, and USA 300. To confirm the anti-MRSA activity of 2-PyDC, bacterial growth inhibition rate using time-kill curves was evaluated. The concentration-dependent inhibition of 2-PyDC on the growth of S. aureus (ATCC 29213), MRSA (XJ 75302), Mu50, and USA 300 was consistent with the MIC results, wherein 32 or 64 µg/mL 2-PyDC significantly inhibited the growth of MRSA. However, compared with 2-PyDC, other three compounds exerted almost no effect on any S. aureus in the MIC or growth inhibition rate experiments.
The experiment results also showed that all four compounds consisted of a 4-hydroxycoumarin dimer containing two classical intramolecular O-H···O HBs, which were considered as important factors in assisting the molecule to obtain the correct configuration for biological activity [19] . The calculated results were credible based on the fact that the fully optimized molecular structures of DC calculated at B3LYP level of the theory using three different basis sets (6-31G*, 6-31+G** and 6-311G*) were in agreement with its available X-ray data.
Because of the three different pyridine rings individually introduced in the methylene bridge destroying the symmetrical structure of DC, the calculated ρ b and ▽ 2 ρ b for the O···H bonding in the upper exocyclic ring were higher than that in the lower exocyclic ring for compounds 2-PyDC, 3-PyDC, 4-PyDC. Based on the same reason, the total HB stabilization energies in 2-PyDC, 3-PyDC, and 4-PyDC were estimated to be −64.94, −70.33 and −68.77 kJ/mol, respectively, which were lower than that in compound DC. These values suggest that the most potent antibacterial activity in 2-PyDC correlated with its weakest total HB energy in the four compounds.
Conclusion
More appropriate antibiotics should be developed to treat infected patients because of the emergence of methicillin-resistant, vancomycin-intermediate resistant, or multi-drug resistant S. aureus. Among the the four compounds, 2-PyDC exhibited the most potent anti-bacterial efficiency, possibly because the 2-pyridine group on the methylene group further weakened the HB strengths. The character of much less toxicity to mammalian cells also exhibits the potential antimicrobial applications. To further define the mechanism underlying the anti-bacterial activity of the derivative and evaluate correlations with its drug efficacy in vivo, additional experiments should be carried out.
Experimental
Apparatus and materials
IR spectra (400-4000 cm -1 ) were obtained using a Brucker Equinox-55 spectrophotometer.
1 H NMR spectra were obtained using a Varian Inova-400 spectrometer (at 400 MHz). Mass spectra were obtained using a micrOTOF-Q II mass spectrometer. The melting points were taken on a XT-4 micro melting apparatus, and the thermometer was uncorrected. All antibiotics used were purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). All other chemicals and solvents were of analytical grade.
MRSA (XJ 75302) was isolated from cultures of sputum samples from patients in Xijing Hospital (Xi'an, China). S. aureus strain (ATCC 29213) was purchased from the Chinese National Center for Surveillance of Antimicrobial Resistance. Mu50 (ATCC 700699) and USA 300 (LAC) were purchased from MicroBiologics (MN, USA).
Synthesis and characterization of DC, 2-PyDC, 3-PyDC and 4-PyDC
DC, 2-PyDC, 3-PyDC and 4-PyDC were synthesized according to the methods of a previous report [20] . A mixture of formaldehyde (or pyridine-2-carbaldehyde, pyridine-3-carbaldehyde and pyridine-4-carbaldehyde) (10 mmol) and 4-hydroxycoumarin (20 mmol) was dissolved in 100 mL of EtOH. A few drops of piperidine were added, and the mixture was stirred for 3 h at room temperature. After reaction completion as determined by TLC, water was added until precipitation occurred. After filtering the precipitates, they were sequentially washed with ice-cooled water and ethanol and then dried in a vacuum.
3,3′-Methylenedi(4-hydroxycoumarin) (dicoumarol, 
X-ray crystallography
For X-ray diffraction experiments, single crystals of compound DC were both grown from methanol. The X-ray diffraction data were collected on a Bruker SMART APEX II CCD diffractometer equipped with a graphite monochromated Mo Kα radiation (λ = 0.71073 Å) by using the ω-2θ scan technique at room temperature. The structure was solved by direct methods using SHELXS-97 [21] and refined using the full-matrix least squares method on F 2 with anisotropic thermal parameters for all non-hydrogen atoms by using SHELXL-97. Hydrogen atoms were generated geometrically. The crystal data and details concerning data collection and structure refinement are given in Table 6 . Molecular illustrations were prepared using the XP package. Parameters in CIF format are available as Electronic Supplementary Publication from Cambridge Crystallographic Data Centre. Table 6 Crystal data, data collection and structure refinement of compound DC 
Quantum chemical calculations
All calculations were carried out using the Gaussian 09 package [22] . Density functional theory (DFT) [23, 24] , Becke's three-parameter hybrid function (B3LYP) [25] , and LYP correlation function [26, 27] were used to fully optimize all the geometries on the energy surface without constraints. To obtain precise results that are in conjunction with experimental results, three basis sets, namely 6-31G*, 6-31+G**, and 6-311G*, were tested. Frequency calculations at the B3LYP (with basis sets 6-31G*) level of theory were carried out to confirm stationary points as minima and to obtain the zero-point energies and the thermal correlation data at 1 atm and 298 K.
Minimal inhibitory concentration (MIC) assay
Based on the CLSI broth microdilution method [28] , the determination of minimum inhibitory concentrations (MICs) via microdilution assay was performed in sterilized 96-well polypropylene microtiter plates (Sigma-Aldrich) in a final volume of 200 µL. Bacteria were grown overnight in nutrient broth. Mueller-Hinton (MH) broth (100 µL) containing bacteria (5 × 10 5 CFU/mL) was added to 100 µL of the culture medium containing the test compound (0.12 µg/mL to 256 µg/mL in serial twofold dilutions). The plates were incubated at 37 °C for 20 h in an incubator. About 50 µL of 0.2% triphenyl tetrazolium chloride (TTC), a colorimetric indicator, was added to each well of microtiter plates and incubated at 35 °C for 1.5 h. The TTC-based MIC was determined as the lowest concentration of oxacillin that showed no red color change indicating complete growth inhibition.
Bacterial growth inhibition
To obtain the time-kill curves for methicillin-susceptible S. aureus and MRSA, the synthetic compounds and antibiotics were added to strain cultures to a final concentration of 4, 8, 16, 32 or 64 µg/mL [29] . The strains were cultivated in the automated Bioscreen C system (Lab systems Helsinki, Finland) by using an MH broth culture medium. The working volume in the wells of the Bioscreen plate was 300 µL, which comprised 150 µL of the MH broth and 150 µL of the drug solution. The temperature was controlled at 35°C, and the optical density of the cell suspensions was measured automatically at 600 nm in regular intervals of 10 min for 20 h. Before each measurement, the culture wells were automatically shaken for 60 s. Statistical data for each experiment were obtained from at least two independent assays performed in duplicate.
Cytotoxicity assay
The cytotoxicity of compounds to the human umbilical vein endothelial cells (HUVECs) and human embryonic cardiomyocytes cell line CCC-HHM-2 (HHHM-2) was determined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) staining. Briefly, cells (5×10 3 cells/well) were seeded in a 96-well plate with 100 µL DMEM media with 20% fetal bovine serum (FBS) in every well for 12 hours, and then treated with or without compounds at various concentrations (12.5-800 µg/mL) for 24 hours. After treatment, MTT solution (final concentration, 0.5%) was added and cells were incubated for another 4 hours at 37°C. 150 µL DMSO was added to each well after removal of the supernatant and the absorbance at 490 nm was measured with a microplate reader.
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